13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13G Filed 2026-06-05 Event — SEC 0001104659-26-071013 →

ADAR1 Capital Management, LLC Rallybio Corporation RLYB

Stake: Shares: CUSIP: 75120L209 Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
3 13D/G filings on this issuer
2 other filings besides this one
Filer Track Record
3 filings by this filer
2 other filings in the data moat
Short Interest · settle 2026-07-15
DTC 3.54
170,156 shares short · -58.4% vs prior

Institutional Consensus · 2026-03-31

Held by elite portfolio managers
1 holder · $4.70M
Viking Global

Other 13D/G Filings on Rallybio Corporation

FiledFormFilerStakeShares
2024-01-02 SC Novo Holdings A/S view →
2022-01-18 SC TPG GP A, LLC view →

Other Filings by ADAR1 Capital Management, LLC

FiledFormIssuerStakeShares
2026-06-05 SCHEDULE 13G InMed Pharmaceuticals, Inc. INM view →
2025-04-28 SCHEDULE Keros Therapeutics, Inc. KROS 13.29% 5,390,964 view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →